Cianna picks up $10M to expand its cancer-fighting device

Aliso Viejo, CA's Cianna Medical has locked down a credit facility worth up to $10 million, cash the company will use to market its device designed to deliver radiation treatment to patients with early-stage breast cancer. The money comes courtesy of GE Capital, and Cianna said it will bankroll the U.S. and international commercialization of its SAVI device, a brachytherapy system that has been used to treat more than 20,000 women around the world. News

Suggested Articles

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.